Dr. Megan Clarke earned an M.H.S. in biochemistry and molecular biology in 2010 and a Ph.D. in epidemiology in 2016, both from the Johns Hopkins Bloomberg School of Public Health. She completed a postdoctoral fellowships in the Clinical Genetics Branch (NCI). She was promoted to research fellow in 2019 and was appointed as an Earl Stadtman Tenure-Track Investigator in 2020. Her work focuses on evaluation of biomarkers for prevention of cervical and anal cancers.